Patients With Type B Aortic Dissection Returning to Work After Discharge:a Cross-sectional Survey

Cross-sectional Survey and Prediction Model Construction of Patients With Type B Aortic Dissection Returning to Work After Discharge

This study wants to understand the incidence of returning to work after discharge in patients with type B aortic dissection.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

The incidence of aortic dissection in China is increasing year by year. According to the latest research report, the annual incidence of aortic dissection in China is 5 ~ 10 / 100,000, the average age of patients is 51.8 years old, and the age of disease is about 10 years younger than that of European and American countries. RTW after discharge is a measure of disease recovery and recovery to normal state. There are only reports on RTW after discharge in the fields of cancer, stroke, organ transplantation, maintenance peritoneal dialysis and so on. Most of the existing literature in the cardiovascular field at home and abroad focuses on assessing the status of RTW and RRTW after discharge. Up to now, there is still a lack of research on the promotion and hindrance factors of RTW in TBAD patients, the status survey of post-RTW work ability and the related nomogram prediction model. Therefore, based on the Meleis transformation theory, this study aims to investigate the current status of return to work of TBAD patients at 6 months after discharge through quantitative and qualitative research, and to explore its influencing factors in depth. Based on the previous results, the RTW visual prediction model of TBAD patients was constructed, which provided a theoretical basis for the formulation and implementation of early intervention by medical staff, and further improved the research in this field.

Study Type

Observational

Enrollment (Estimated)

178

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Yanjuan Lin, MD
  • Phone Number: +86 591 8621 8336
  • Email: fjxhyjl@163.com

Study Locations

    • Fujian
      • Fuzhou, Fujian, China, 350000
        • Recruiting
        • Fujian Medical University Union Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

This study selected patients with TBAD who were hospitalized in the Department of Cardiac Surgery, Union Hospital Affiliated to Fujian Medical University.

Description

Inclusion Criteria:

( 1 ) TBAD was diagnosed by computed tomography angiography ( CTA ) or magnetic resonance angiography ( MRA ) ; ( 2 ) 18 years ≤ age < 60 years at diagnosis ; ( 3 ) having full-time or part-time job at the time of diagnosis ; ( 4 ) TBAD patients were discharged after successful treatment and the discharge time was ≥ 6 months ;

Exclusion Criteria:

( 1 ) reaching the retirement age 6 months after discharge ; ( 2 ) those with disturbance of consciousness, mental illness, inability to complete the interview independently or under the guidance of the researcher ; ( 3 ) Participate in other related research ; ( 4 ) Clinical end-stage or receiving palliative treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Return to work group
Asked whether the patient returned to work, if the patient returned to work, included in this group.
Ask patients if they are going back to work
Non-return to work group
Ask whether the patient returned to work, if the patient did not return to work, included in this group.
Ask patients if they are going back to work

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of return to work
Time Frame: Six months after discharge,
the incidence of returning to work was calculated according to whether the included patients could return to work.
Six months after discharge,

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Estimated)

November 30, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

May 14, 2024

First Submitted That Met QC Criteria

May 14, 2024

First Posted (Actual)

May 17, 2024

Study Record Updates

Last Update Posted (Actual)

May 17, 2024

Last Update Submitted That Met QC Criteria

May 14, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type B Aortic Dissection

Clinical Trials on return to work

Subscribe